AAAAAA
Results:
1-11
|
Results: 11
Authors:
Duffaud, F
van der Burg, MEL
Namer, M
Vergote, I
Willemse, PHB
Huinink, WT
Guastalla, JP
Nooij, MA
Kerbrat, P
Piccart, M
Tumolo, S
Favalli, G
van der Vange, N
Lacave, AJ
Wils, J
Splinter, TAW
Einhorn, N
Roozendaal, KJ
Rosso, R
Vermorken, JB
Citation: F. Duffaud et al., D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTCgynaecological cancer co-operative group study, ANTI-CANC D, 12(2), 2001, pp. 159-162
Authors:
Wagenaar, HC
Pecorelli, S
Vergote, I
Curran, D
Wagener, DJT
Kobierska, A
Bolis, G
ten Bokkel-Huinink, W
Lacave, AJ
Madronal, C
Forni, M
de Oliveira, CF
Mangioni, C
Nooij, MA
Goupil, A
Kerbrat, P
Marth, C
Tumolo, S
Herben, MG
Zanaboni, F
Vermorken, JB
Citation: Hc. Wagenaar et al., Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced Fallopian tube carcinoma - An EORTC Gynecological Cancer Group Study, EUR J GYN O, 22(3), 2001, pp. 187-193
Authors:
Nicoletto, MO
Artioli, G
Donach, M
Sileni, VC
Monfardini, S
Talamini, R
Veronesi, A
Ferrazzi, E
Tumolo, S
Visona, E
Amichetti, M
Endrizzi, L
Salvagno, L
Prosperi, A
Azzoni, P
Citation: Mo. Nicoletto et al., Elderly ovarian cancer: Treatment with mitoxantrone-carboplatin, GYNECOL ONC, 80(2), 2001, pp. 221-226
Authors:
Pujol, JL
von Pawel, J
Tumolo, S
Martoni, A
Hearn, S
Fields, SZ
Ross, G
Citation: Jl. Pujol et al., Preliminary results of combined therapy with topotecan and carboplatin in advanced non-small-cell lung cancer, ONCOL-BASEL, 61, 2001, pp. 47-54
Authors:
Piccart, MJ
Bertelsen, K
James, K
Cassidy, J
Mangioni, C
Simonsen, E
Stuart, G
Kaye, S
Vergote, I
Blom, R
Grimshaw, R
Atkinson, RJ
Swenerton, KD
Trope, C
Nardi, M
Kaern, J
Tumolo, S
Timmers, P
Roy, JA
Lhoas, F
Lindvall, B
Bacon, M
Birt, A
Andersen, JE
Zee, B
Paul, J
Baron, B
Pecorelli, S
Citation: Mj. Piccart et al., Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: Three-year results, J NAT CANC, 92(9), 2000, pp. 699-708
Authors:
Aita, P
Robieux, I
Sorio, R
Tumolo, S
Corona, C
Cannizzaro, R
Colussi, AM
Boiocchi, M
Toffoli, G
Citation: P. Aita et al., Pharmacokinetics of oral etoposide in patients with hepatocellular carcinoma, CANC CHEMOT, 43(4), 1999, pp. 287-294
Authors:
Pawinski, A
Tumolo, S
Hoesel, G
Cervantes, A
van Oosterom, AT
Boes, GH
Pecorelli, S
Citation: A. Pawinski et al., Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative Group, EUR J OB GY, 86(2), 1999, pp. 179-183
Authors:
Lo Re, G
Buonadonna, A
Duati, M
Colussi, AM
Canzonieri, V
Frustaci, S
Morassut, S
Cimitan, M
Tumolo, S
Citation: G. Lo Re et al., Efficacy of total androgen blockade in metastatic prostatic carcinoma withtransient hypogonadotropic hypogonadism: A case report, TUMORI, 85(4), 1999, pp. 280-283
Authors:
Toffoli, G
Tumolo, S
Citation: G. Toffoli et S. Tumolo, Prognostic significance of folate-binding protein in ovarian neoplasia, TUMORI, 85(3), 1999, pp. S39-S41
Authors:
Santarosa, M
Dolcetti, R
Magri, MD
Crivellari, D
Tibiletti, MG
Gallo, A
Tumolo, S
Della Puppa, L
Furlan, D
Boiocchi, M
Viel, A
Citation: M. Santarosa et al., BRCA1 and BRCA2 genes: Role in hereditary breast and ovarian cancer in Italy, INT J CANC, 83(1), 1999, pp. 5-9
Authors:
Toffoli, G
Sorio, R
Gallo, A
Cernigoi, C
Boiocchi, M
Zarrelli, A
Tumolo, S
Scarabelli, C
Citation: G. Toffoli et al., Folate binding protein as a prognostic marker in ovarian cancers, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 323-326
Risultati:
1-11
|